Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-123

Thanks for the constructive comments.(Yes. I lost over $200,000 in one short period during 2016 holding the stock through one of the previous large dilutional CR) I was a true believer (once) who couldn't hold on for personal financial reasons. I was basically over exposed.There has been no other agenda - other than to support other RI's through these subsequent tough times, post an alternative view of the way their funds have been managed by this company (contrary to others who continually put a positive spin on the stock), and to try ask questions to find out just why the company had failed to grow RI capital over the last 4-5 years.

One of my main griefs was the way dilutional CR in the past had caught out existing holders (and diluted their holdings) and help explain to other RI's - just how and why that happens. So they aren't caught out (like I was)

I'm glad for other RI's the company appears to have not taken this route on this occasion (as I said that in a recent post today).

Cheers.